Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |